Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.1450 (-0.53%) ($14.1450 - $14.1450) on Sun. Aug. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 42 | Latest Price | $14.1450(-0.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -7.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BCRX price | BCRX will decline at least -1.805% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $2.06(-85.44%) | Resistance Level | $16.05 | 5 Day Moving Average | $14.53(-2.65%) | 10 Day Moving Average | $15.33(-7.73%) | 20 Day Moving Average | $16.05(-11.87%) | To recent high | -20% | To recent low | 6.5% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |